{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:09:23Z","timestamp":1785265763786,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA042014-23"],"award-info":[{"award-number":["5P30CA042014-23"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ygyno.2021.05.034","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T08:23:48Z","timestamp":1622708628000},"page":"454-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up"],"prefix":"10.1016","volume":"162","author":[{"given":"Anthony C.","family":"Casper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Lindsay M.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.05.034_bb0005","series-title":"New Malignancies Among Cancer Survivors [electronic resource]: SEER Cancer Registries, 1973\u20132000","author":"Freedman","year":"2006"},{"key":"10.1016\/j.ygyno.2021.05.034_bb0010","author":"Society"},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.034_bb0015","first-page":"1564","article-title":"Second malignant neoplasms among long-term survivors of ovarian cancer","volume":"56","author":"Travis","year":"1996","journal-title":"Cancer Res."},{"issue":"38","key":"10.1016\/j.ygyno.2021.05.034_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001626","article-title":"Secondary primary malignancy risk in patients with ovarian cancer in Taiwan: a nationwide population-based study","volume":"94","author":"Hung","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.034_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/0003-4819-131-3-199908030-00005","article-title":"Risk for colorectal cancer after gynecologic cancer","volume":"131","author":"Weinberg","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.ygyno.2021.05.034_bb0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.11372","article-title":"Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma","volume":"97","author":"Hemminki","year":"2003","journal-title":"Cancer."},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.034_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/02841869509127185","article-title":"Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study","volume":"34","author":"Bergfeldt","year":"1995","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.034_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3857\/roj.2018.00290","article-title":"Radiation induced secondary malignancies: a review article","volume":"36","author":"Dracham","year":"2018","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/j.ygyno.2021.05.034_bb0045","author":"Network NCC"},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.034_bb0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2018.07.010","article-title":"Diagnosis and treatment of ovarian cancer","volume":"32","author":"Orr","year":"2018","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ygyno.2021.05.034_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fonc.2017.00177","article-title":"Radiation treatment in women with ovarian cancer: past, present, and future","volume":"7","author":"Fields","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2021.05.034_bb0060","series-title":"[dataset] SEER*Stat Databases [Internet]","year":"2021"},{"key":"10.1016\/j.ygyno.2021.05.034_bb0065","series-title":"SEER*Stat. 8.3.8 ed2021","year":"2021"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.034_bb0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.1989.93","article-title":"Subsequent primary cancers in relation to treatment of ovarian cancer","volume":"59","author":"Prior","year":"1989","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2021.05.034_bb0075","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.034_bb0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2008.01.032","article-title":"Increased risk of second cancer among patients with ovarian borderline tumors","volume":"109","author":"Bouchardy","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.05.034_bb0085","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/djt065","article-title":"Disparities in ovarian cancer care quality and survival according to race and socioeconomic status","volume":"105","author":"Bristow","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.034_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13048-017-0355-y","article-title":"Racial health disparities in ovarian cancer: not just black and white","volume":"10","author":"Srivastava","year":"2017","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.034_bb0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/s12885-017-3902-4","article-title":"Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies","volume":"17","author":"Liang","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.034_bb0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaoncol.2018.5625","article-title":"Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era","volume":"5","author":"Morton","year":"2019","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.034_bb0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2021.05.034_bb0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-related myeloid neoplasms: when genetics and environment collide","volume":"17","author":"McNerney","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.034_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199001043220101","article-title":"Leukemia following chemotherapy for ovarian cancer","volume":"322","author":"Kaldor","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ygyno.2021.05.034_bb0120","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1200\/JCO.2014.58.3088","article-title":"Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort","volume":"33","author":"Westmaas","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.034_bb0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2013.04.469","article-title":"Involved-field radiation therapy for locoregionally recurrent ovarian cancer","volume":"130","author":"Brown","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.05.034_bb0130","first-page":"1","article-title":"Adjuvant treatment of early ovarian clear cell carcinoma: a population-based study of whole abdominal versus pelvic nodal radiotherapy","author":"Roy","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"26","key":"10.1016\/j.ygyno.2021.05.034_bb0135","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001079","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.034_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910630102","article-title":"Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study","volume":"63","author":"Kaldor","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.034_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.breast.2017.07.004","article-title":"Risk of secondary malignancies after radiation therapy for breast cancer: comprehensive results","volume":"35","author":"Burt","year":"2017","journal-title":"Breast."},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.034_bb0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11764-019-00771-z","article-title":"Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors","volume":"13","author":"Loomer","year":"2019","journal-title":"J. Cancer Surviv."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.034_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2009.07.1692","article-title":"A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations","volume":"78","author":"Brown","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821004406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821004406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:13Z","timestamp":1758772633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821004406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0090825821004406"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.034","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}